Navigation Links
W.M. Keck Foundation Awards $1 Million to Hutchinson Center Scholar to Study How Cells Go Awry

SEATTLE, Aug. 3 /PRNewswire/ -- Anyone touched by the ravages of cancer knows the rapidly growing, opportunistic cells don't play fair. But in order to expose exactly how cancer cells cheat their host, scientists must first study the rules governing the orderly cooperation of normal cells.

For creating a system that studies the rules governing cellular order - which enhances the potential for learning how cancer cells cheat - Fred Hutchinson Cancer Research Center basic scientist Wenying Shou, Ph.D., has been named among the W.M. Keck Foundation's 2009 class of Distinguished Young Scholars in Medical Research. Shou is among five U.S. scientists tapped to receive the five-year, $1 million award, established by Keck to provide resources to promising young scientists in pursuit of groundbreaking biomedical research.

Shou, an assistant member of the Center's Basic Sciences Division, studies social interactions between cells. Her lab set up an artificial system in which two sets of yeast cells are forced to cooperate when each lacks the ability to make an essential nutrient required for life. Each strain's essential nutrient is available in the other, so the two organisms can live together but not on their own. The system accommodates ongoing, quantitative measurements of population size and interaction and is compatible with mathematical modeling.

Shou and her colleagues are now investigating what happens when a third type of cell, a "cheater," which requires a nutrient but gives nothing back, is introduced into the system. The lab also looks into the role of spatial structure in stabilizing cooperation among cells.

Shou completed her postdoctoral work in quantitative biology at the Rockefeller University and in computational biology at Memorial Sloan-Ketting Cancer Center. She earned her doctorate from the California Institute of Technology.

Other Young Scholars awardees from the Hutchinson Center have included Adrian Ferre-D'Amare, Ph.D., of the Basic Sciences Division (2003) and Bruce Clurman, M.D., Ph.D., of the Clinical Research and Human Biology divisions (1999).

The W.M. Keck Foundation is a leading supporter of high-impact medical research, science and engineering. Established in 1998, the Keck Distinguished Young Scholars in Medical Research program was designed to support groundbreaking research addressing the fundamental mechanisms of human disease. 54 young investigators have received funding. More information about the Keck Foundation and its Young Scholars program is available at

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit

    Christi Ball Loso

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
7. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
8. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
9. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... 2 nouvelles études permettent d , identifier ... souches bactériennes retrouvées dans la plaque dentaire des ... Ces recherches  ouvrent une nouvelle voie ... l,un des problèmes de santé les plus fréquemm ... --> 2 nouvelles études permettent d , ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
Breaking Biology Technology:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
Breaking Biology News(10 mins):